---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-034813"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2024-09-03T23:59:59+00:00"
generated_at: "2026-05-31T06:36:13.401851+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Xtant files updated Surgalign historical financials in support of S-3 registration

## Summary
- Filing includes Surgalign's unaudited financials for H1 2023 and FY2022, and pro forma combined data for FY2023.
- Surgalign H1 2023 revenue $30.3M (down from $41.2M); net income $5.8M vs loss $5.7M, driven by Coflex sale and warrant liability changes.
- Pro forma info is presented for informational purposes and does not project future results.
- No current operational update or guidance for Xtant is provided in this filing.

## SEC filing metadata
- accession: 0001493152-24-034813
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2024-09-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315224034813/0001493152-24-034813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315224034813/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-034813
- JSON: https://secwatch.observer/filing/0001493152-24-034813.json
- Plain text: https://secwatch.observer/filing/0001493152-24-034813.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.